Literature DB >> 1722965

Neurogenic component of different models of acute inflammation in the rat knee joint.

F Y Lam1, W R Ferrell.   

Abstract

This study was performed to investigate whether different models of acute joint inflammation showed a neurogenic component and to establish whether this is mediated through sensory afferent or sympathetic efferent nerve fibres. Intra-articular injection of 2% carrageenan, 20 micrograms substance P, 1% formalin, and 2% urate all produced an inflammatory response. Prior surgical denervation of the joint significantly inhibited this response in the carrageenan and formalin models, but not the others. Pretreatment of the joint with 1% capsaicin (about one week previously) significantly reduced the inflammatory response in all models except formalin. In animals pretreated long term with reserpine (to deplete sympathetic nerve endings of their neurotransmitters) significant reductions occurred in the inflammatory responses to substance P and urate. Intraarticular injection of compound 48/80 produced a marked inflammatory response, which was only significantly reduced by capsaicin pretreatment. These results suggest that both the formalin and carrageenan models of inflammation depend to some extent on the integrity of the sensory innervation of the joint, and thus have a neurogenically mediated component to the inflammatory process they generate. In these models there seems to be little contribution from sympathetic efferent fibres. Each model of inflammation showed a different pattern of response to the pretreatments, suggesting that the mediators of the inflammatory process may differ in each case.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722965      PMCID: PMC1004549          DOI: 10.1136/ard.50.11.747

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Release of 5-hydroxytryptamine and histamine from tissues of the rat.

Authors:  J R PARRATT; G B WEST
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

2.  On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb, and on the nature of these fibres.

Authors:  W M Bayliss
Journal:  J Physiol       Date:  1901-02-28       Impact factor: 5.182

3.  The influence of the sympathetic nervous system on capillary permeability.

Authors:  D Engel
Journal:  J Physiol       Date:  1941-01-14       Impact factor: 5.182

4.  Unmedullated fibers originating in dorsal root ganglia.

Authors:  H S GASSER
Journal:  J Gen Physiol       Date:  1950-07-20       Impact factor: 4.086

Review 5.  Peptides and neurogenic inflammation.

Authors:  J C Foreman
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

6.  Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease.

Authors:  E S Kimball; F J Persico; J L Vaught
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

7.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin.

Authors:  N Jancsó; A Jancsó-Gábor; J Szolcsányi
Journal:  Br J Pharmacol Chemother       Date:  1967-09

8.  Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetized cat.

Authors:  W R Ferrell; N J Russell
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

9.  Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis.

Authors:  M Lotz; D A Carson; J H Vaughan
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

10.  Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist.

Authors:  F Y Lam; W R Ferrell
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

View more
  9 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint.

Authors:  Joseph R Ghilardi; Katie T Freeman; Juan M Jimenez-Andrade; Kathleen A Coughlin; Magdalena J Kaczmarska; Gabriela Castaneda-Corral; Aaron P Bloom; Michael A Kuskowski; Patrick W Mantyh
Journal:  Arthritis Rheum       Date:  2012-07

3.  Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat.

Authors:  F Y Lam; M C Wong
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 4.  The sympathetic nervous system and tendinopathy: a systematic review.

Authors:  Jacob L Jewson; Gavin W Lambert; Michael Storr; James E Gaida
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

5.  Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats.

Authors:  Francis F Y Lam; Ethel S K Ng
Journal:  Br J Pharmacol       Date:  2010-01-29       Impact factor: 8.739

6.  Acute joint inflammation alters the adrenoceptor profile of synovial blood vessels in the knee joints of rabbits.

Authors:  E Gray; W R Ferrell
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

7.  Capsazepine reversal of the antinociceptive action of capsaicin in vivo.

Authors:  M N Perkins; E A Campbell
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Joint inflammation is reduced by dorsal rhizotomy and not by sympathectomy or spinal cord transection.

Authors:  K A Sluka; N B Lawand; K N Westlund
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

9.  Pain relief by extracorporeal shockwave therapy: an update on the current understanding.

Authors:  Christoph Schmitz; Rocco DePace
Journal:  Urol Res       Date:  2009-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.